# abrdn Platinum ETF Trust: financial statements, quarterly

PPLT · NYSE · CIK 1460235 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pplt.md) · [Financials](/companies/pplt/financials.md) · [Filings](/companies/pplt/filings.md) · [Insiders](/companies/pplt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pplt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [26.5](/filings/0001999371-24-014547.md) | [75.9 d](/filings/0001999371-26-004969.md) | [(93.3)](/filings/0001999371-25-005704.md) | [107](/filings/0001999371-25-010850.md) | [(28.4)](/filings/0001999371-25-017268.md) | [(80.3) d](/filings/0001999371-26-004969.md) | [84.8](/filings/0001999371-26-010354.md) | [402](/filings/0001999371-26-017414.md) | [259](/filings/0001999371-25-017268.md) | [595 d](/filings/0001999371-26-004969.md) | [(184)](/filings/0001999371-26-010354.md) | [(401)](/filings/0001999371-26-017414.md) |
| Basic EPS | $ per share | [2.47](/filings/0001999371-24-014547.md) | not reported | [(8.47)](/filings/0001999371-25-005704.md) | [9.50](/filings/0001999371-25-010850.md) | [(2.55)](/filings/0001999371-25-017268.md) | not reported | [7.17](/filings/0001999371-26-010354.md) | [3.35](/filings/0001999371-26-017414.md) | [19.77](/filings/0001999371-25-017268.md) | not reported | [(12.05)](/filings/0001999371-26-010354.md) | [(2.99)](/filings/0001999371-26-017414.md) |

- Gross profit: not reported
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [910](/filings/0001839882-23-030162.md) | [998](/filings/0001839882-25-012448.md) | [920](/filings/0001999371-24-005862.md) | [1,030](/filings/0001999371-24-009836.md) | [1,001](/filings/0001999371-24-014547.md) | [1,019](/filings/0001999371-26-004969.md) | [1,065](/filings/0001999371-25-005704.md) | [1,618](/filings/0001999371-25-010850.md) | [1,959](/filings/0001999371-25-017268.md) | [2,864](/filings/0001999371-26-017414.md) | [2,398](/filings/0001999371-26-010354.md) | [1,774](/filings/0001999371-26-017414.md) |
| Total liabilities | $m | [0.4](/filings/0001839882-23-030162.md) | [0.5](/filings/0001839882-25-012448.md) | [0.5](/filings/0001999371-24-005862.md) | [0.5](/filings/0001999371-24-009836.md) | [0.5](/filings/0001999371-24-014547.md) | [0.5](/filings/0001999371-26-004969.md) | [0.5](/filings/0001999371-25-005704.md) | [0.8](/filings/0001999371-25-010850.md) | [0.9](/filings/0001999371-25-017268.md) | [1.4](/filings/0001999371-26-017414.md) | [1.3](/filings/0001999371-26-010354.md) | [0.9](/filings/0001999371-26-017414.md) |
| Shareholders' equity | $m | [909](/filings/0001999371-24-014547.md) | [997](/filings/0001999371-26-004969.md) | [920](/filings/0001999371-25-010850.md) | [1,030](/filings/0001999371-25-017268.md) | [1,001](/filings/0001999371-25-017268.md) | [1,019](/filings/0001999371-26-017414.md) | [1,065](/filings/0001999371-26-017414.md) | [1,617](/filings/0001999371-26-017414.md) | [1,958](/filings/0001999371-25-017268.md) | [2,863](/filings/0001999371-26-017414.md) | [2,397](/filings/0001999371-26-017414.md) | [1,773](/filings/0001999371-26-017414.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2011-03-31) | Q2 FY2011 (2011-06-30) | Q3 FY2011 (2011-09-30) | Q4 FY2011 (2011-12-31) | Q1 FY2012 (2012-03-31) | Q2 FY2012 (2012-06-30) | Q3 FY2012 (2012-09-30) | Q4 FY2012 (2012-12-31) | Q1 FY2013 (2013-03-31) | Q2 FY2013 (2013-06-30) | Q3 FY2013 (2013-09-30) | Q4 FY2013 (2013-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.0](/filings/0000930413-12-002976.md) | [0.0](/filings/0000930413-12-004463.md) | [0.0](/filings/0001460235-12-000004.md) | [0.0 d](/filings/0001460235-14-000002.md) | [0.0](/filings/0001460235-13-000005.md) | [0.0](/filings/0001460235-13-000026.md) | [0.0](/filings/0001460235-13-000029.md) | [0.0 d](/filings/0001460235-15-000002.md) | [0.0](/filings/0001460235-14-000005.md) | [0.0](/filings/0001460235-14-000007.md) | [0.0](/filings/0001460235-14-000011.md) | [0.0 d](/filings/0001460235-16-000017.md) |
| Share repurchases | $m | [114](/filings/0000930413-12-002976.md) | [96.9](/filings/0000930413-12-004463.md) | [118](/filings/0001460235-12-000004.md) | [52.7 d](/filings/0001460235-14-000002.md) | [40.7](/filings/0001460235-13-000005.md) | [29.9](/filings/0001460235-13-000026.md) | [55.9](/filings/0001460235-13-000029.md) | [48.2 d](/filings/0001460235-15-000002.md) | [8.0](/filings/0001460235-14-000005.md) | [27.1](/filings/0001460235-14-000007.md) | [86.9](/filings/0001460235-14-000011.md) | [40.8 d](/filings/0001460235-16-000017.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 128,000,000 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001999371-26-017414.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.